Rain Therapeutics Inc. (NASDAQ:RAIN) Q2 2023 Earnings Call Transcript August 10, 2023
Rain Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.49.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Rain Oncology Inc. Second Quarter 2023 Earnings Conference Call. At this time, all lines are in listen-only mode and following the presentation we will conduct a question-and-answer session. [Operator Instructions] This call is being...
